Publications by authors named "Shou Nitta"
Infect Dis Ther
January 2022
Article Synopsis
- This study explored whether tocilizumab, used to treat COVID-19, affects the likelihood of bacteremia and impacts fever and inflammation levels in patients.
- Conducted from March 2020 to August 2021, the research analyzed the health outcomes of 144 patients, splitting them into those treated with tocilizumab and those who were not.
- The findings showed that while tocilizumab treatment lowered C-reactive protein levels, indicating reduced inflammation, it did not increase bacteremia risk or significantly affect fever, suggesting the need for careful fever monitoring in patients.
Infect Dis Ther
February 2022
Article Synopsis
- The study investigated the effects of tocilizumab, a treatment for COVID-19, on the incidence of bacteremia as well as its impact on fever and inflammatory markers in patients.
- It involved 144 patients, finding that 13 out of 24 with bacteremia had received tocilizumab, but the treatment did not significantly increase bacteremia risk or reduce fever.
- The conclusion suggests that while tocilizumab lowers C-reactive protein levels, it does not heighten bacteremia risk, indicating the need for monitoring fever to avoid overlooking potential infections.
